课题基金 / 基金详情

BIOCHEMICAL MECHANISMS OF DRUG RESISTANCE IN HIV 1 RT

BIOCHEMICAL MECHANISMS OF DRUG RESISTANCE IN HIV 1 RT
HIV 1 RT 耐药性的生化机制
批准号:
2871544
负责人:
WALTER A SCOTT
金额:
$26.97万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-15 至 2000-01-14

项目摘要

项目成果

WALTER A SCOTT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from Applicant's Abstract): The investigators propose to study the mechanism of AZT resistance and suppression of AZT resistance by suppressor mutations. They well also study RT mutations that alter catalytic activity, non-nucleoside RT inhibitors, and various nucleotide analogues. They propose to characterize quantitatively the formation of conformationally active stable complex formed between HIV-1 RT, primer-template, and deoxyribonucleoside triphosphate (dNTP) when phosphodiester bond synthesis is prevented. They well monitor the formational changes that occur in the formation of stable complex by measuring nuclease protection, dissociation rate in absence of dNTP, circular dichroism spectral changes, and changes in intrinsic protein fluorescence. In addition, they will study the effects of these mutations on RNase H endonuclease and exonuclease activity. Finally, they well characterize a novel AZTTP-dependent DNA modifying activity of HIV-1 RT that they recently identified. The unifying hypothesis is that drug-resistance mutations render the enzyme less effective at DNA chain termination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BIOCHEMICAL MECHANISMS OF DRUG RESISTANCE IN HIV-1 RT
Biochemical Mechanisms of Drug Resistance in HIV-1 RT
Biochemical Mechanisms of Drug Resistance in HIV-1 RT
Biochemical Mechanisms of Drug Resistance in HIV RT
海外基金